These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 34757217)
41. Delafloxacin: design, development and potential place in therapy. Candel FJ; Peñuelas M Drug Des Devel Ther; 2017; 11():881-891. PubMed ID: 28356714 [TBL] [Abstract][Full Text] [Related]
42. Mohamed NM; Zakaria AS; Edward EA; Abdel-Bary A Pol J Microbiol; 2019; 68(1):59-69. PubMed ID: 31050254 [TBL] [Abstract][Full Text] [Related]
43. Acyloxymethyl as a drug protecting group. Part 7: Tertiary sulfonamidomethyl ester prodrugs of benzylpenicillin: chemical hydrolysis and anti-bacterial activity. Iley J; Barroso H; Moreira R; Lopes F; Calheiros T Bioorg Med Chem; 2000 Jul; 8(7):1629-36. PubMed ID: 10976510 [TBL] [Abstract][Full Text] [Related]
45. Moxifloxacin Derivatives with Potential Antibacterial Activity against Methicillin- Resistant Staphylococcus Aureus (MRSA). Chen R; Xue H; Xu Y; Ma T; Liu Y; Zhang J; Shi X; Guo D Curr Top Med Chem; 2021; 21(27):2474-2482. PubMed ID: 34645377 [TBL] [Abstract][Full Text] [Related]
46. Chemistry, Biological Properties and Analytical Methods of Levonadifloxacin: A Review. Lautre C; Sharma S; Sahu JK Crit Rev Anal Chem; 2022; 52(5):1069-1077. PubMed ID: 33307757 [TBL] [Abstract][Full Text] [Related]
47. Prodrugs of E-selectin Antagonists with Enhanced Pharmacokinetic Properties. Dätwyler P; Jiang X; Wagner B; Varga N; Mühlethaler T; Hostettler K; Rabbani S; Schwardt O; Ernst B ChemMedChem; 2022 Jan; 17(1):e202100634. PubMed ID: 34870892 [TBL] [Abstract][Full Text] [Related]
48. Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus. Kaul M; Mark L; Parhi AK; LaVoie EJ; Pilch DS Antimicrob Agents Chemother; 2016 Jul; 60(7):4290-6. PubMed ID: 27161635 [TBL] [Abstract][Full Text] [Related]
49. Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084. Isoda T; Ushirogochi H; Satoh K; Takasaki T; Yamamura I; Sato C; Mihira A; Abe T; Tamai S; Yamamoto S; Kumagai T; Nagao Y J Antibiot (Tokyo); 2006 Apr; 59(4):241-7. PubMed ID: 16830892 [TBL] [Abstract][Full Text] [Related]
54. Design, synthesis, and antibacterial evaluation of novel derivatives of NPS-2143 for the treatment of methicillin-resistant S. aureus (MRSA) infection. Chen Y; Ju Y; Li C; Yang T; Deng Y; Luo Y J Antibiot (Tokyo); 2019 Jul; 72(7):545-554. PubMed ID: 30940910 [TBL] [Abstract][Full Text] [Related]
55. 4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: novel C7 moieties of fluoroquinolones as antibacterial agents. Huang X; Zhang A; Chen D; Jia Z; Li X Bioorg Med Chem Lett; 2010 May; 20(9):2859-63. PubMed ID: 20347299 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives. Wang JX; Zhang YB; Liu ML; Wang B; Chai Y; Li SJ; Guo HY Eur J Med Chem; 2011 Jun; 46(6):2421-6. PubMed ID: 21481984 [TBL] [Abstract][Full Text] [Related]
57. Synthesis, chemical and enzymatic hydrolysis, and aqueous solubility of amino acid ester prodrugs of 3-carboranyl thymidine analogs for boron neutron capture therapy of brain tumors. Hasabelnaby S; Goudah A; Agarwal HK; abd Alla MS; Tjarks W Eur J Med Chem; 2012 Sep; 55():325-34. PubMed ID: 22889558 [TBL] [Abstract][Full Text] [Related]
58. Riccardin C derivatives as anti-MRSA agents: structure-activity relationship of a series of hydroxylated bis(bibenzyl)s. Sawada H; Okazaki M; Morita D; Kuroda T; Matsuno K; Hashimoto Y; Miyachi H Bioorg Med Chem Lett; 2012 Dec; 22(24):7444-7. PubMed ID: 23122868 [TBL] [Abstract][Full Text] [Related]
59. Synthesis, stability and in vitro dermal evaluation of aminocarbonyloxymethyl esters as prodrugs of carboxylic acid agents. Mendes E; Furtado T; Neres J; Iley J; Jarvinen T; Rautio J; Moreira R Bioorg Med Chem; 2002 Mar; 10(3):809-16. PubMed ID: 11814870 [TBL] [Abstract][Full Text] [Related]
60. Progress towards a stable cephalosporin-halogenated phenazine conjugate for antibacterial prodrug applications. Xiao T; Liu K; Huigens RW Bioorg Med Chem Lett; 2020 Nov; 30(22):127515. PubMed ID: 32860978 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]